US conditionally clears Integra/Codman Neuro after UK waves through
Integra LifeSciences has agreed to divest a range of healthcare product lines to nab US clearance for its acquisition of Johnson & Johnson’s neurosurgery medical products business – a deal already unconditionally cleared in the UK on the de minimis exception.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10